NRx Pharmaceuticals NRXP Stock
3.04 USD
{{ price }}
1.333330%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
49M USD
LOW - HIGH [24H]
4.9
-
6 USD
VOLUME [24H]
1.12M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4 USD
NRx Pharmaceuticals Price Chart
NRx Pharmaceuticals NRXP Financial and Trading Overview
| NRx Pharmaceuticals stock price | 3.04 USD |
| Previous Close | 0.54 USD |
| Open | 0.55 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 42300 |
| Day's Range | 0.53 - 0.55 USD |
| 52 Week Range | 0.49 - 1.54 USD |
| Volume | 426.52K USD |
| Avg. Volume | 288.11K USD |
| Market Cap | 37.26M USD |
| Beta (5Y Monthly) | 0.956338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.67 USD |
NRXP Valuation Measures
| Enterprise Value | 33.21M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3947368 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.872 |
Trading Information
NRx Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.956338 |
| 52-Week Change | -2.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.54 USD |
| 52 Week Low | 0.49 USD |
| 50-Day Moving Average | 0.62 USD |
| 200-Day Moving Average | 0.87 USD |
NRXP Share Statistics
| Avg. Volume (3 month) | 288.11K USD |
| Avg. Daily Volume (10-Days) | 1.11M USD |
| Shares Outstanding | 70.31M |
| Float | 44.79M |
| Short Ratio | 10.12 |
| % Held by Insiders | 39.16% |
| % Held by Institutions | 4.50% |
| Shares Short | 1.27M |
| Short % of Float | 3.01% |
| Short % of Shares Outstanding | 1.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -72.77% |
| Return on Equity (ttm) | -237.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -38061000 USD |
| Net Income Avi to Common (ttm) | -37345000 USD |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.51M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 12.19M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.986 |
| Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35464000 USD |
| Levered Free Cash Flow (ttm) | -24193624 USD |
Profile of NRx Pharmaceuticals
| Country | United States |
| State | DE |
| City | Wilmington |
| Address | 1201 Orange Street |
| ZIP | 19801 |
| Phone | (484) 254-6134 |
| Website | https://www.nrxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Q&A For NRx Pharmaceuticals Stock
What is a current NRXP stock price?
NRx Pharmaceuticals NRXP stock price today per share is 3.04 USD.
How to purchase NRx Pharmaceuticals stock?
You can buy NRXP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NRx Pharmaceuticals?
The stock symbol or ticker of NRx Pharmaceuticals is NRXP.
Which industry does the NRx Pharmaceuticals company belong to?
The NRx Pharmaceuticals industry is Biotechnology.
How many shares does NRx Pharmaceuticals have in circulation?
The max supply of NRx Pharmaceuticals shares is 16.12M.
What is NRx Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
NRx Pharmaceuticals PE Ratio is now.
What was NRx Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
NRx Pharmaceuticals EPS is -4 USD over the trailing 12 months.
Which sector does the NRx Pharmaceuticals company belong to?
The NRx Pharmaceuticals sector is Healthcare.
NRx Pharmaceuticals NRXP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}